Aging on purpose. Strength, longevity & preventive health after 50. Down 170 lbs on TRT + GLP-1. I read the studies, track my labs and test this stuff on myself
Boston, MA
Joined September 2025
- Tweets327
- Following107
- Followers60
- Likes111
Pinned Tweet
I’m Gunnar. I’m over 50, down roughly 170 lbs, lift regularly, and use TRT + a GLP-1 prescribed by my doctor.
I became interested in something pretty simple: how do you get older without surrendering muscle, cardiovascular health or independence — and how much of the longevity industry is actually supported by evidence?
So I read the studies, track my own labs and write about what I find.
Strength training. Obesity medicine. TRT. Preventive health. Longevity. Occasionally calling bullshit.
That’s DadStrengthDaily.
I don’t understand why @YouTube bans my channel (with 4 subscribers) making me feel like a criminal while allowing massive amounts of videos promoting sale of illegal drugs (various peptides including Retatrutide). They are clearly complicit and the @FDA doesn’t seem to enforce anything.
@statnews @adamyamaguchi
1
28
Like for example how does this guy promoting a store with an affiliate code selling Retatrutide not get banned?? @TeamYouTube
There are thousands of videos like that on YouTube who is caching the ad money.
30
YouTube terminated my channel. Then YouTube TV, Premium and NFL Sunday Ticket stopped working all paid for.
Every online way to cancel, even @TeamYouTube's refund form, ends on a channel removed notice.
I think that violates Massachusetts law. @MassAGO
Next bill: Nov 27 @YouTubeTV
1
2
180
I wrote it up, including the Massachusetts rule I think this breaks: dadstrengthdaily.com/youtube…
1
91
I criticize peptide sellers often enough that people call me a Big Pharma shill. YouTube just terminated my channel under its regulated goods rules. No warning, no strike, appeal denied the same night.
At the same time lots of illegal peptide sellers’ videos on dosing retatrutide are still up. 🤷♂️🤯
dadstrengthdaily.com/youtube…
1
2
80
And YouTube premium support was supremely unhelpful. Really not a great experience @sundarpichai @YouTubeCreators @nealmohan
1
51
A drug cut Lp(a) by 78%. Major heart events: 12.3% on it, 12.1% on placebo. Oops.
We have seen this in drug development before. In 5 of these 8 trials, the drug moved its marker and patients got no benefit or were even harmed.
better lab number are interesting, but an outcome trial is what matters
2
51
Why the marker and the outcome come apart, and the two trials where they didn't:
dadstrengthdaily.com/does-lo…
6
Gunnar · DadStrengthDaily retweeted
💊 STREAM (NEJM): stopping statins at 70+ cost 2.0 wks of event-free time over 2 yrs, yet "noninferior" (margin 5.2 wks)
🚫 Even a PERFECT statin (zero MI, zero stroke, zero CV ☠️) buys only ~3.5–4 wks
⚠️ The margin was unreachable
Most lost time = non-CV death
Stroke Before 55 Is Still Rare. High Blood Pressure Is the Biggest Risk Factor.
dadstrengthdaily.substack.co…
8
My AI checker flagged two slips in Riemann's 1859 paper, the one behind the $1M Riemann hypothesis prize.
Both are real. They came in when the German was retyped in LaTeX in 1998, and the English translation the @ClayInstitute posts still has them.
55
I built an AI checker for scientific papers and ran it on 849 of them.
In 489, it found a number, sign, formula or claim that contradicts the paper itself, and a second AI model from another company agreed.
One: the retatrutide TRIUMPH-1 abstract in NEJM lost a minus sign.
3
1
117
NEJM's Oct 22 update has the minus sign back.
Most slips like this don't change a paper's conclusion. In my hand check, about 91% of the top-grade flags I could judge were real. It also raises false alarms, and it can't tell what it misses.
1
23
Authors should run a check like this before they submit, the way everyone runs a spell checker.
Write-up, with slips in the Zepbound and orforglipron trials, AlphaGo and PageRank: dadstrengthdaily.com/errors-…
All 849 papers: ai-papercheck.pages.dev
25
A federal judge today denied Novo's request to pull Lilly's Zepbound vs Wegovy and Mounjaro vs Ozempic ads.
Novo argued the trials behind them skipped its newer, higher doses. The judge said Novo hadn't shown harm: its prescriptions held steady while the ads ran.
The judge also found Novo had run the same kind of ad: Ozempic-beats-Trulicity claims after Lilly's higher Trulicity doses were approved, with no disclaimer. Novo pulled them days before suing.
The case continues. Opinion:
storage.courtlistener.com/re…
This is wild. My Nest Protects all loudly announce *every* evening when I turn off the lights that they are going to expire in 3 months! Who thought that is a good idea?!
FWIW, I already ordered replacements but still have to listen to this every night!
Cc @googlenesthelp
1
1
469
I checked 93 stores that list "research use only" peptides like retatrutide and BPC-157.
23 openly publish mixing or dosing instructions, a dosing calculator, or health claims. Another 24 list bacteriostatic water.
19 of the 93 already have an FDA warning letter.
6
3
287
The label has not held up in court. Paradigm Peptides told the FDA in 2022 its products were "for research only" and sold until 2024. Its owner got 70 months in July: unapproved drugs sold with intent to defraud, plus illegal imports.
Part 1 of 3: dadstrengthdaily.com/researc…
53